DAC MEETING OUTCOME
DAC meetings are held quarterly each year to evaluate new drug applications for listing in the HA Drug Formulary. DAC’s Recommendation will be sent to the concerned Cluster / Hospital DTCs after the DAC meetings. The recommended drugs will be posted in the web after the meetings and the recommended drugs will be listed on the HA Drug Formulary in around two months after the meetings.
DAC meeting outcomes in the past 3 years are set out below:-
Feb 2025 meeting (Outcomes/ Reference List)
Oct 2024 meeting (Outcomes/ Reference List)
Jul 2024 meeting (Outcomes/ Reference List)
Apr 2024 meeting (Outcomes/ Reference List)
Jan 2024 meeting (Outcomes/ Reference List)
Oct 2023 meeting (Outcomes/ Reference List)
Jul 2023 meeting (Outcomes/ Reference List)
Apr 2023 meeting (Outcomes/ Reference List)
Jan 2023 meeting (Outcomes/ Reference List)
Oct 2022 meeting (Outcomes/ Reference List)
Jul 2022 meeting (Outcomes/ Reference List)
Apr 2022 meeting (Outcomes/ Reference List)